Abstract
Background
Global prevalence of obesity has soared. Where lifestyle and medical treatments have failed, laparoscopic sleeve gastrectomy (LSG) is increasingly regarded as a good surgical procedure for morbid obesity. Following the introduction of LSG, we assessed our surgical outcomes.
Methods
We reviewed a consecutive series of LSGs from January 2009 to January 2015. Our primary focus was to assess the success of this procedure on the percentage excess body weight loss (%EWL), Body Mass Index (BMI), hypertension and diabetes. Additionally, we evaluated the rate of procedure-related complications.
Results
There were 183 consecutive patients evaluated. Median age was 45 years (24–73). The majority were female (73.2 %, n = 134). At 1 year post-op, median %EWL was 57.6 %. There was an associated median reduction in BMI of 16 kg/m2 (0–33). At 2 years, median %EWL was sustained at 58.4 %. The median reduction in BMI was 16 kg/m2 (4–32). At 2-year post-op, 78.9 % of diabetic patients had their diabetic medications completely discontinued, while a further 15.8 % having their medication reduced. 34.6 % of hypertensive patients had their antihypertensives discontinued, with 50 % having medications reduced. There was no procedure related mortality. 3.3 % (n = 6) of patients had a confirmed staple-line leak.
Conclusion
This study shows LSG is a safe and successful management strategy for morbid obesity. In addition to the direct effects of sustained weight loss, it highlights indirect effects that LSG has on obesity-related health issues, with substantial reduction in diabetic and anti-hypertensive medications. Our results reaffirm international studies of the beneficial effects of LSG on Type II diabetes and hypertension.
Similar content being viewed by others
References
Roth J et al (2004) The obesity pandemic: where have we been and where are we going? Obes Res 12(Suppl 2):88S–101S
Ng M et al (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384(9945):766–781
Crowe C et al (2015) Effects of an eight-week supervised, structured lifestyle modification programme on anthropometric, metabolic and cardiovascular risk factors in severely obese adults. BMC Endocr Disord 15:37
Guh DP et al (2009) The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9:88
Lim SS et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2224–2260
Ochner CN et al (2015) Treating obesity seriously: when recommendations for lifestyle change confront biological adaptations. Lancet Diabetes Endocrinol 3(4):232–234
Wadden TA, Butryn ML, Wilson C (2007) Lifestyle modification for the management of obesity. Gastroenterology 132(6):2226–2238
Kissane NA, Pratt JS (2011) Medical and surgical treatment of obesity. Best Pract Res Clin Anaesthesiol 25(1):11–25
Fisher BL, Schauer P (2002) Medical and surgical options in the treatment of severe obesity. Am J Surg 184(6B):9S–16S
Hubbard VS, Hall WH (1991) Gastrointestinal surgery for severe obesity. Obes Surg 1(3):257–265
Chang KH et al (2010) Sustained weight loss and improvement of quality of life after laparoscopic adjustable gastric banding for morbid obesity: a single surgeon experience in Ireland. Ir J Med Sci 179(1):23–27
Li JF et al (2013) Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Can J Surg 56(6):E158–E164
Li P et al (2013) Laparoscopic Roux-en-Y gastric bypass vs. laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus: a meta-analysis of sixteen recent studies. Hepatogastroenterology 60(121):132–137
Gill RS et al (2010) Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis 6(6):707–713
International Expert, C (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7):1327–1334
Colagiuri S (2011) Glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus—practical implications. Diabetes Res Clin Pract 93(3):312–313
James PA et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507–520
Mechanick JI et al (2008) American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract 14(Suppl 1):1–83
Regan JP et al (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13(6):861–864
Baltasar A et al (2005) Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg 15(8):1124–1128
Zhang Y et al (2015) Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obes Surg 25(1):19–26
Angrisani L et al (2015) Bariatric surgery worldwide 2013. Obes Surg 25(10):1822–1832
Esteban Varela J et al (2015) Laparoscopic sleeve gastrectomy leads the US utilization of bariatric surgery at academic medical centers. Surg Obes Relat Dis 11(5):987–990
Sarkhosh K et al (2012) The impact of sleeve gastrectomy on hypertension: a systematic review. Obes Surg 22(5):832–837
Lee CM, Cirangle PT, Jossart GH (2007) Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc 21(10):1810–1816
Milone L, Strong V, Gagner M (2005) Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI ≥50). Obes Surg 15(5):612–617
Nocca D et al (2008) A prospective multicenter study of 163 sleeve gastrectomies: results at 1 and 2 years. Obes Surg 18(5):560–565
Trastulli S et al (2013) Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis 9(5):816–829
Zacharoulis D et al (2012) Influence of the learning curve on safety and efficiency of laparoscopic sleeve gastrectomy. Obes Surg 22(3):411–415
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of outcomes or interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. As this was a retrospective studies, formal consent is not required.
Funding
This study received no funding.
Rights and permissions
About this article
Cite this article
Moloney, B.M., Hynes, D.A., Kelly, M.E. et al. The role of laparoscopic sleeve gastrectomy as a treatment for morbid obesity; review of outcomes. Ir J Med Sci 186, 143–149 (2017). https://doi.org/10.1007/s11845-016-1484-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-016-1484-9